Tatva Chintan Pharma Chem Limited IPO: Issue Price, Listing Gain and Share Price Now
Tatva Chintan Pharma Chem Limited listed on 29-Jul-2021 at ₹2,310.25 against an issue price of ₹1,083 , a listing gain of +113.32%. It last traded at ₹1,637.75. This page is the record of that issue and what has happened to it since — reported figures only.
Tatva Chintan Pharma Chem Limited IPO: listing gain and return since
| Measure | Value |
|---|---|
| Issue price | ₹1,083 |
| Listing price (listing-day close) | ₹2,310.25 |
| Listing gain | +113.32% |
| Price now | ₹1,637.75 |
| Change from issue price | +51.22% |
| Change from listing-day close | -29.11% |
The two changes above answer different questions and are routinely opposite in sign. The change from the issue price is what an allottee has made. The change from the listing-day close is what somebody who bought on the first day has made.
Tatva Chintan Pharma Chem Limited IPO details
| Issue term | Detail |
|---|---|
| Issue price (upper band) | ₹1,083 |
| Issue size | ₹500 Cr |
| Fresh issue | ₹225 Cr |
| Offer for sale | ₹275 Cr |
| Issue opened | 16-Jul-2021 |
| Issue closed | 20-Jul-2021 |
| Listed on | 29-Jul-2021 |
| Exchange | BSE, NSE |
| Segment | Mainboard |
| Lead managers | ICICI Securities (left lead) |
How the Tatva Chintan Pharma Chem Limited IPO was subscribed
| Category | Subscription |
|---|---|
| QIB | 185.23x |
| NII | 512.22x |
| Retail | 35.35x |
| Total | 180.36x |
Tatva Chintan Pharma Chem Limited today
| Figure | Value |
|---|---|
| Market capitalisation | ₹3,833 Cr |
| Trailing P/E | 73.20x |
| Return on capital employed | 7.1% |
| Return on equity | 5.5% |
| 52-week high | ₹1,839 |
| 52-week low | ₹976 |
| Sector | Specialty Chemicals |
Fundamentals are as of the desk's last harvest and move with the market.
- Tatva Chintan Pharma Chem Limited — full issue page: every stored figure, with its source.
- How many IPOs still trade above their issue price, corporate-action adjusted.
- The full IPO archive: listing gains by year, sector and issue size.
Automated data digest. This page is compiled automatically from exchange filings and public aggregator data. It is a record of reported figures — it is not research, not a recommendation, and not investment advice.
Grey Market Premium (GMP) is an unofficial, unregulated price quoted outside the exchanges. It is not a forecast of the listing price and is frequently wrong.
Published by INVESTOLOGY — SEBI Registered Research Analyst INH000015297. Investments in securities markets are subject to market risk; read all offer documents carefully before investing. Registration granted by SEBI and NISM certification in no way guarantee performance or assure returns.